Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation

Chemico-Biological Interactions

Volumn 155, Issue 1-2, 2005, Pages 55-61

  Rickert, D E ^a   Dingley, K ^b   Ubick, E ^b   Dix, K J ^c   Molina, L ^c  

^a Lawrence Livermore National Laboratory ^*

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c Lantibio Inc   (United States)

Author keywords

Accelerator mass spectrometry; Cystic fibrosis; Distribution; Dog; Moli1901; Pharmacokinetics

Indexed keywords

CARBON 14; DURAMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG INSTILLATION; DRUG RETENTION; DRUG TISSUE LEVEL; FECES; KIDNEY; LIVER; LUNG LOBE; MALE; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; URINE;

ANIMALS; CARBON RADIOISOTOPES; CYSTIC FIBROSIS; DOGS; INTUBATION, INTRATRACHEAL; LUNG; MALE; MASS SPECTROMETRY; PARTICLE ACCELERATORS; PEPTIDES, CYCLIC;

CANIS FAMILIARIS;

EID: 20644458109     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.04.002     Document Type: Article

References (20)

1. O.L. Shotwell, F.H. Stodola, W.R. Michael, L.A. Lindenfelser, R.G. Dworschack, and T.G. Pridham Antibiotics against plant disease. III. Duramycin, a new antibiotic from Streptomyces cinnamomeus forma azacoluta J. Am. Chem. Soc. 80 1958 3912 3914
2. F. Hayashi, K. Nagashima, Y. Terui, Y. Kawamura, K. Matsumoto, and H. Itazaki The structure of PA48009: the revised structure of duramycin J. Anitbiot. 43 1990 1421 1430
3. M.M. Cloutier, L. Guernsey, P. Mattes, and B. Koeppen Duramycin enhances chloride secretion in airway epithelium Am. J. Physiol. 259 1990 450 454
4. M.M. Cloutier, L. Guernsey, and R.I. Sha'afi Duramycin increases intracellular calcium in airway epithelium Membr. Biochem. 10 1993 107 118
5. L. Molina y Vedia, M.J. Stutts, R.C. Boucher, D.C. Henke, Method of treating retained pulmonary secretions. US Patent 5,512,269 (1996).
6. D.C. Henke, M.J. Stutts, R. Harvey, and L. Molina Bioelectric and fluid transport effects of the nonadecapeptide 2622U90 (duramycin) in normal human cystic fibrosis airway epithelium and canine airways Ped. Pulmonol. Suppl. 17 1998 238
7. P.L. Zeitlin, M. Boyle, W.B. Guggino, and L. Molina A phase I trial of intranasal Moli1901 for cystic fibrosis Chest 125 2004 143 149
8. M.J. McNulty, R.H. Hutabarat, J.W.A. Findlay, K. Devereux, V.C. Knick, R.J. Harvey, and L. Molina Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice Xenobiotica 13 2003 197 210
9. M.J. McNulty, R.H. Hutabarat, R.J. Harvey, and L. Molina The disposition of the nonadecapeptide, duramycin, in the beagle dog after inhalation exposure ISSX Proc. 12 1997 123
10. K.W. Turteltaub, and J.S. Vogel Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research Curr. Pharm. Des. 6 2000 991 1007
11. J.S. Vogel Rapid production of graphite without contamination for biomedical AMS Radiocarbon 34 1992 344 350
12. 14C via accelerator mass spectrometry Anal. Chem. 75 2003 2192 2196
13. 14C-quantification of biochemical samples Int. J. Mass Spectrom. 218 2002 255 264
14. J. Navarro, K. Chabot, K. Sherrill, R. Aneja, S.A. Zahler, and E. Racker Interaction of duramycin with artificial and natural membranes Biochemistry 24 1985 4645 4650
15. P.M. Sokolove, P.A. Westphal, M.B. Kester, R. Wierwille, and K. Sikora-VanMeter Duramycin effects on the structure and function of heart mitochondria. I. Structural alterations and changes in membrane permeability Biochim. Biophys. Acta 983 1989 15 22
16. 1H NMR analyses in dimethyl sulfoxide solution Biochemistry 29 1990 113 118
17. S.Y. Choung, T. Kobayashi, K. Takemoto, H. Ishitsuka, and K. Inoue Interaction of a cyclic peptide, Ro09-0198 with phosphatidylethanolamine In liposomal membranes Biochim. Biophys. Acta 940 1988 180 187
18. Y. Aoki, T. Uenaka, J. Aoki, M. Umeda, and K. Inoue A novel peptide probe for studying the transbilayer movement of phosphatidylethanolamine J. Biochem. 116 1994 291 297
19. J.S. Patton, and R.M. Platz Routes of delivery: case studies. Pulmonary delivery of peptides and proteins for systemic action Adv. Drug Deliv. Rev. 8 1992 179 196
20. A.N.O. Dodoo, S. Bansal, D.J. Bablow, E.C. Bennet, R.C. Hider, A.B. Lansley, M.J. Lawrence, and C. Marriott Systemic investigations of the influence of molecular structure on the transport of peptides across cultured alveolar cell monolayers Pharm. Res. 17 2000 7 14